浙江停售叠加份额跌穿55%,东阳光药“流感神药”双线告急

新浪财经
Jun 21

本报(chinatimes.net.cn)记者于娜 北京报道近日,浙江省医保局一则药品价格调整公示,将多家药企生产的磷酸奥司他韦胶囊推向风口浪尖。其中,东阳光长江药业的“可威”磷酸奥司他韦胶囊被暂停挂网,原因涉及价格投诉。这一消息,无疑给其母公司广东东阳光药业股份有限公司(下称“东阳光药”)赴港上市之路蒙上了一层阴影。(来源:浙江省医保局官网)对于暂停挂网的影响,东阳光药向《华夏时报》记者表示,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10